絞り込み

16555

広告

Comparison of the early effects of vonoprazan, lansoprazole and famotidine on intragastric pH: a three-way crossover study.

著者 Ohkuma K , Iida H , Inoh Y , Kanoshima K , Ohkubo H , Nonaka T , Fujita K , Kusakabe A , Inamori M , Nakajima A
J Clin Biochem Nutr.2018 Jul ; 63(1):80-83.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (38view , 0users)

Full Text Sources

Miscellaneous

To promote symptom relief from acid-related diseases, a medicine with a rapid-onset effect is ideal. The aim of this study was to investigate the early inhibitory effect on gastric acid secretion after a single oral administration of vonoprazan, which represents a new class of proton pump inhibitors, and to compare this effect with those of lansoprazole and famotidine. Ten ()-negative male subjects participated in this randomized, three-way crossover study. A single oral administration of vonoprazan (20 mg), lansoprazole (30 mg) or famotidine (20 mg) was performed, and the intragastric pH was continuously monitored for 6 h. Each drug was administered at least seven days apart. The average intragastric pH during the 6-h period after the administration of famotidine was higher than that after the administration of lansoprazole (median: 4.45 vs 2.65;  = 0.0284). A similar result was observed for vonoprazan and lansoprazole (median: 4.30 vs 2.65;  = 0.0322). In conclusions, oral administration of vonoprazan and famotidine in -negative healthy male subjects caused the intragastric pH to rise more quickly than did lansoprazole. (Trial Registration: UMIN000020989).
PMID: 30087548 [PubMed]
印刷用ページを開く Endnote用テキストダウンロード